Sign in Subscribe
Biochemistry

Unconventional Role of CXCL2 in Liver Cancer Offers New Therapeutic Target

Strategic Insights

— 1 min read

Research has identified the unconventional role of CXCL2 in regulating neutrophil polarization and immune responses in hepatocellular carcinoma (HCC), positioning it as a potential therapeutic target for the disease. According to a study published in Advanced Science, CXCL2, a chemokine ligand, plays a crucial role in shaping the HCC microenvironment by inhibiting cholesterol biosynthesis. The study also highlights the importance of identifying key genes and developing effective strategies for reshaping the HCC microenvironment.

Key Takeaways:

  • Hepatocellular carcinoma (HCC) is a major cause of cancer-related death worldwide, with a large proportion of patients failing to benefit from immunotherapy due to their immunosuppressive microenvironment.
  • The study identified a significant downregulation of C-X-C motif chemokine ligand 2 (CXCL2) in HCC due to gene copy number loss, which correlates with poor prognosis and suboptimal responsiveness to immunotherapy.
  • CXCL2 can not only recruit neutrophils but also induce their polarization toward the antitumor type, curbing HCC progression.
  • Intracellular CXCL2 binds to Y-Box Binding Protein 1 (YBX1) and prevents its nuclear translocation, reducing the transcription of sterol regulatory element binding transcription factor 2 (SREBF2) and suppressing cholesterol biosynthesis.
  • The study emphasizes the need to identify key genes and develop effective strategies for reshaping the HCC microenvironment to improve immunotherapy outcomes.

Statistics:

  • 1 in 5 patients with HCC fail to benefit from immunotherapy due to their immunosuppressive microenvironment (Source: NewsRx)
  • CXCL2 is significantly downregulated in HCC due to gene copy number loss (Source: Advanced Science)
  • Inhibition of cholesterol biosynthesis causes a significant reduction in HCC development (Source: Advanced Science)

Sources:

  • NewsRx. New Liver Cancer Study Findings Recently Were Reported by Researchers at Peking University Health Science Center (Tumor Cell-Derived CXCL2 Potentiates Neutrophil-Mediated Antitumor Immunity by Inhibiting Cholesterol Biosynthesis in ...). Cancer Weekly. November 4, 2025; p 115.
  • Advanced Science. Tumor Cell-Derived CXCL2 Potentiates Neutrophil-Mediated Antitumor Immunity by Inhibiting Cholesterol Biosynthesis in Hepatocellular Carcinoma. Wiley, 111 River St, Hoboken 07030-5774, NJ, USA.

Read more